CA2194909A1 - Tissue injectable composition and method of use - Google Patents

Tissue injectable composition and method of use

Info

Publication number
CA2194909A1
CA2194909A1 CA2194909A CA2194909A CA2194909A1 CA 2194909 A1 CA2194909 A1 CA 2194909A1 CA 2194909 A CA2194909 A CA 2194909A CA 2194909 A CA2194909 A CA 2194909A CA 2194909 A1 CA2194909 A1 CA 2194909A1
Authority
CA
Canada
Prior art keywords
tissue
injectable composition
tissue site
composition
tissue injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2194909A
Other languages
French (fr)
Other versions
CA2194909C (en
Inventor
Timothy Paul Lawin
Jeffrey Michael Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carbon Medical Technologies Inc
Original Assignee
Timothy Paul Lawin
Jeffrey Michael Williams
Advanced Uroscience, Inc.
Brennen Medical, Inc.
Carbon Medical Technologies Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23049577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2194909(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Timothy Paul Lawin, Jeffrey Michael Williams, Advanced Uroscience, Inc., Brennen Medical, Inc., Carbon Medical Technologies Inc. filed Critical Timothy Paul Lawin
Publication of CA2194909A1 publication Critical patent/CA2194909A1/en
Application granted granted Critical
Publication of CA2194909C publication Critical patent/CA2194909C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A61L27/303—Carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389—The prosthesis being coated or covered with a particular material
    • A61F2310/00574—Coating or prosthesis-covering structure made of carbon, e.g. of pyrocarbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Abstract

An improved biocompatible composition consisting of physiologically stable microparticles carried in a lubricative suspension, solution, other fluid or gel is presented. The composition is intended to be delivered into the body through a small-bore needle, cannula, or catheter and to a tissue site for the purpose of augmenting the tissue site and surrounding area, thereby con-ectlng a defect, filling a void, or strengthening the support structures of the tissue. The particles are a hard, metallic substance and are carbon-coated.
CA002194909A 1994-07-14 1995-06-13 Tissue injectable composition and method of use Expired - Fee Related CA2194909C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/274,777 1994-07-14
US08/274,777 US5451406A (en) 1994-07-14 1994-07-14 Tissue injectable composition and method of use
PCT/US1995/007454 WO1996002209A1 (en) 1994-07-14 1995-06-13 Tissue injectable composition and method of use

Publications (2)

Publication Number Publication Date
CA2194909A1 true CA2194909A1 (en) 1996-02-01
CA2194909C CA2194909C (en) 1999-07-13

Family

ID=23049577

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194909A Expired - Fee Related CA2194909C (en) 1994-07-14 1995-06-13 Tissue injectable composition and method of use

Country Status (6)

Country Link
US (1) US5451406A (en)
EP (1) EP0771179B1 (en)
AT (1) ATE246475T1 (en)
CA (1) CA2194909C (en)
DE (1) DE69531450T2 (en)
WO (1) WO1996002209A1 (en)

Families Citing this family (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US6051247A (en) * 1996-05-30 2000-04-18 University Of Florida Research Foundation, Inc. Moldable bioactive compositions
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US5792478A (en) * 1996-07-08 1998-08-11 Advanced Uro Science Tissue injectable composition and method of use
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
EP0925077B1 (en) * 1996-08-23 2003-10-15 Cook Biotech, Inc. Method for obtaining a purified collagen-based matrix from submucosa tissue
US6645138B2 (en) 1997-09-12 2003-11-11 Uromedica, Inc. Adjustable implantable genitourinary device
US6419624B1 (en) 1999-10-11 2002-07-16 Uromedica, Inc. Apparatus and method for inserting an adjustable implantable genitourinary device
US6045498A (en) 1997-06-12 2000-04-04 Uromedica, Inc. Method for adjustably restricting a body lumen
US6579224B1 (en) * 1999-10-11 2003-06-17 Uromedica, Inc. Apparatus and method for inserting an adjustable implantable genitourinary device
US7364540B1 (en) 1997-06-12 2008-04-29 Uromedica, Inc. Implantable device and method for adjustably restricting a body lumen
FR2764514B1 (en) 1997-06-13 1999-09-03 Biopharmex Holding Sa IMPLANT INJECTED IN SUBCUTANEOUS OR INTRADERMAL WITH CONTROLLED BIORESORBABILITY FOR REPAIR OR PLASTIC SURGERY AND AESTHETIC DERMATOLOGY
JP2001509419A (en) * 1997-07-10 2001-07-24 ユーエスバイオマテリアルズ コーポレイション Moldable bioactive composition
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6309420B1 (en) 1997-10-14 2001-10-30 Parallax Medical, Inc. Enhanced visibility materials for implantation in hard tissue
US20030135206A1 (en) * 1998-02-27 2003-07-17 Curon Medical, Inc. Method for treating a sphincter
AU742786B2 (en) 1998-03-06 2002-01-10 Biosphere Medical, Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
AU3203599A (en) * 1998-04-01 1999-10-18 Parallax Medical, Inc. Pressure applicator for hard tissue implant placement
US6161034A (en) * 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6238335B1 (en) 1998-12-11 2001-05-29 Enteric Medical Technologies, Inc. Method for treating gastroesophageal reflux disease and apparatus for use therewith
US7132582B2 (en) * 2003-05-30 2006-11-07 Council Of Scientific And Industrial Research Catalytic process for the preparation of isolongifolene
US6595910B2 (en) * 1998-12-11 2003-07-22 Scimed Life Systems, Inc. Method for treating fecal incontinence
US6251064B1 (en) * 1998-12-11 2001-06-26 Enteric Medical Technologies, Inc. Method for creating valve-like mechanism in natural body passageway
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US20090030309A1 (en) 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
JP2002537910A (en) * 1999-03-01 2002-11-12 アドバンスト バイオメディカル デバイシィズ インコーポレイテッド Implant positioning system and method
WO2000056254A1 (en) 1999-03-24 2000-09-28 Parallax Medical, Inc. Non-compliant system for delivery of implant material
ATE427074T1 (en) 1999-04-30 2009-04-15 Uromedica Inc DEVICE HAVING AN ADJUSTABLE SLING FOR TREATING STRESS-RELATED URINARY INCONTINENCE
US20040229295A1 (en) * 1999-05-17 2004-11-18 Marchitto Kevin S. Activated delivery of biomolecules using electromagnetic energy
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6835200B2 (en) * 1999-06-22 2004-12-28 Ndo Surgical. Inc. Method and devices for tissue reconfiguration
US8287554B2 (en) 1999-06-22 2012-10-16 Ethicon Endo-Surgery, Inc. Method and devices for tissue reconfiguration
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US6821285B2 (en) 1999-06-22 2004-11-23 Ndo Surgical, Inc. Tissue reconfiguration
US7846180B2 (en) 1999-06-22 2010-12-07 Ethicon Endo-Surgery, Inc. Tissue fixation devices and methods of fixing tissue
CA2380932A1 (en) * 1999-08-13 2001-02-22 Bioform Inc. Tissue augmentation material and methods
US6358197B1 (en) 1999-08-13 2002-03-19 Enteric Medical Technologies, Inc. Apparatus for forming implants in gastrointestinal tract and kit for use therewith
US6277392B1 (en) * 1999-09-16 2001-08-21 Carbon Medical Technologies, Inc. Tissue injectable composition
US6431174B1 (en) * 2000-08-10 2002-08-13 Pi Medical, Inc. Method and apparatus to treat conditions of the naso-pharyngeal area
US6502574B2 (en) 1999-09-17 2003-01-07 Pi Medical, Inc. Lateral stiffening snoring treatment
US6783515B1 (en) 1999-09-30 2004-08-31 Arthrocare Corporation High pressure delivery system
EP1114618A3 (en) 2000-01-04 2001-08-22 Ethicon Endo-Surgery, Inc. Surgical instrument for applying beads to tissue
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP1274472A2 (en) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
WO2001072281A2 (en) * 2000-03-24 2001-10-04 Biosphere Medical Inc. Microspheres for active embolization
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6355275B1 (en) 2000-06-23 2002-03-12 Carbon Medical Technologies, Inc. Embolization using carbon coated microparticles
WO2002011696A2 (en) * 2000-08-08 2002-02-14 Ev & M Active tissue augmentation materials and method
US6394965B1 (en) 2000-08-15 2002-05-28 Carbon Medical Technologies, Inc. Tissue marking using biocompatible microparticles
US6425854B1 (en) * 2000-10-02 2002-07-30 Genyx Medical, Inc. Method for delivering non-biodegradable bulking composition to a urological site
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6576226B1 (en) 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
EP1919388B1 (en) 2000-11-20 2012-12-26 Senorx, Inc. Tissue site markers for in vivo imaging
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20070191964A1 (en) * 2001-04-04 2007-08-16 Arthrocare Corporation Enhanced visibility materials for implantation in hard tissue
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
US20030161824A1 (en) * 2002-02-27 2003-08-28 Rackley Raymond R. Bulking agent needle apparatus and method of using the needle apparatus
US20030171451A1 (en) * 2002-03-11 2003-09-11 White Daniel A. Bony tissue fillers and restoratives containing biocompatible particle
US7695427B2 (en) 2002-04-26 2010-04-13 Torax Medical, Inc. Methods and apparatus for treating body tissue sphincters and the like
US20040105890A1 (en) * 2002-05-28 2004-06-03 Carbon Medical Technologies, Inc. Biocompatible injectable materials
US7175589B2 (en) * 2002-07-02 2007-02-13 The Foundry Inc. Methods and devices for luminal and sphincter augmentation
US20040194266A1 (en) * 2002-08-19 2004-10-07 Carter Linda A. Burn, sunburn, and cellulite treatment system
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
EP1578281A2 (en) * 2002-11-25 2005-09-28 Boston Scientific Limited Injection device for treating mammalian body
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7381222B2 (en) * 2002-12-30 2008-06-03 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US20050119562A1 (en) * 2003-05-23 2005-06-02 Senorx, Inc. Fibrous marker formed of synthetic polymer strands
US7877133B2 (en) * 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
CA2534033A1 (en) * 2003-07-30 2005-02-10 Anteis S.A. Complex matrix for biomedical use
JP2005161028A (en) * 2003-10-20 2005-06-23 Greatbatch-Hittman Inc Implantable electrical lead wire
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US20060241339A1 (en) * 2005-02-23 2006-10-26 Cook Timothy C Method and apparatus for an adjustable implantable continence device
US20100261951A1 (en) * 2004-02-23 2010-10-14 Uromedica, Inc. Method and apparatus for an adjustable implantable continence device
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
WO2005118060A2 (en) * 2004-04-30 2005-12-15 Boston Scientific Limited Apparatus with partially insulated needle for measuring tissue impedance and method using same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
ATE503465T1 (en) * 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh LOADABLE POLYPHOSPHAZENE-CONTAINING PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND PRODUCTION AND USE METHODS THEREOF
US8663225B2 (en) * 2004-11-12 2014-03-04 Medtronic, Inc. Hydrogel bone void filler
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20060257445A1 (en) * 2005-04-29 2006-11-16 Medtronic, Inc. Devices for augmentation of lumen walls
US20060257444A1 (en) * 2005-04-29 2006-11-16 Medtronic, Inc. Devices for augmentation of lumen walls
CN104815331A (en) 2005-05-09 2015-08-05 生物领域医疗公司 Compositions and methods using microspheres and non-ionic contrast agents
CA2562580C (en) 2005-10-07 2014-04-29 Inrad, Inc. Drug-eluting tissue marker
US20070184087A1 (en) 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
FR2897775B1 (en) * 2006-02-24 2013-05-03 Elisabeth Laugier BIOMATERIAU, INJECTABLE IMPLANT COMPRISING IT, PROCESS FOR PREPARING THE SAME AND USES THEREOF
US8147397B1 (en) 2006-05-19 2012-04-03 Carbon Medical Technologies, Inc. Urethral needle guide device
EP2561842A1 (en) 2006-07-06 2013-02-27 Quiescence Medical Inc Apparatus for treating sleep apnea
US8064987B2 (en) 2006-10-23 2011-11-22 C. R. Bard, Inc. Breast marker
US20080107744A1 (en) * 2006-11-06 2008-05-08 Jack Fa-De Chu Injectable hollow tissue filler
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
ES2432572T3 (en) 2006-12-18 2013-12-04 C.R. Bard, Inc. Biopsy marker with imaging properties generated in situ
US7776840B2 (en) 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
US8852216B2 (en) 2007-03-23 2014-10-07 Ethicon Endo-Surgery, Inc. Tissue approximation methods
JP2010529888A (en) * 2007-06-15 2010-09-02 エシコン・インコーポレイテッド Tissue fragment composition for incontinence treatment
US20090177192A1 (en) * 2007-07-13 2009-07-09 Scimed Life Systems, Inc. Method for ablating tissue to facilitate implantation and apparatus and kit for use therewith
US8262626B2 (en) * 2007-10-23 2012-09-11 Boston Scientific Scimed, Inc. Apparatus and method for treating tissue
EP2222349B1 (en) * 2007-12-17 2014-03-12 Anna Love Soft tissue filler
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
CN102123745A (en) 2008-02-29 2011-07-13 科洛普拉斯特公司 Compositions and methods for augmentation and regeneration of living tissue in a subject
US20100016808A1 (en) * 2008-07-17 2010-01-21 Bioform Medical, Inc. Thin-Walled Delivery System
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
WO2010077244A1 (en) 2008-12-30 2010-07-08 C.R. Bard Inc. Marker delivery device for tissue marker placement
US20100204570A1 (en) * 2009-02-06 2010-08-12 Paul Lubock Anchor markers
US20110098731A1 (en) * 2009-10-26 2011-04-28 Eric Whitbrook Magnetically assisted clasps for prosthetic implants, and related methods
US9700650B2 (en) 2009-11-09 2017-07-11 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US8795727B2 (en) 2009-11-09 2014-08-05 Spotlight Technology Partners Llc Fragmented hydrogels
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
US11918728B2 (en) * 2014-04-17 2024-03-05 ImMutriX Therapeutics, Inc. Therapeutic compositions for viral-associated disease states and methods of making and using same
US9669151B2 (en) * 2014-04-17 2017-06-06 ImMutriX Therapeutics, Inc. Therapeutic compositions for viral-associated disease states and methods of making and using same
US11510766B2 (en) 2019-02-14 2022-11-29 Uromedica, Inc. Method and apparatus for monitoring implantable device for urinary continence

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783868A (en) * 1971-05-06 1974-01-08 Gulf Oil Corp Percutaneous implant
US3977896A (en) * 1972-03-09 1976-08-31 General Atomic Company Process for depositing pyrolytic carbon coatings
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4773393A (en) * 1986-07-03 1988-09-27 C. R. Bard, Inc. Hypodermically implantable genitourinary prosthesis
US5258028A (en) * 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5116387A (en) * 1989-06-09 1992-05-26 American Medical Systems, Inc. Preparation of injectable polymeric bodies
US5158573A (en) * 1989-06-09 1992-10-27 American Medical Systems, Inc. Injectable polymeric bodies
FR2654345A1 (en) * 1989-09-05 1991-05-17 Hamann Sylvie Biocompatible covering consisting of a carbon powder
US5204382A (en) * 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use

Also Published As

Publication number Publication date
WO1996002209A1 (en) 1996-02-01
DE69531450D1 (en) 2003-09-11
US5451406A (en) 1995-09-19
EP0771179A1 (en) 1997-05-07
ATE246475T1 (en) 2003-08-15
EP0771179B1 (en) 2003-08-06
CA2194909C (en) 1999-07-13
DE69531450T2 (en) 2004-05-06
EP0771179A4 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
CA2194909A1 (en) Tissue injectable composition and method of use
US5633001A (en) Composition and a method for tissue augmentation
Ersek et al. Bioplastique: a new textured copolymer microparticle promises permanence in soft-tissue augmentation
AU689622B2 (en) Implant, and method and device for inserting the implant
EP0918498A4 (en) Improved tissue injectable composition and method of use
SE0000285D0 (en) Medical implant
RU97102352A (en) AGENT STIMULATING SOLID FABRIC
JP2694372B2 (en) Microtransplant material
DE69633195D1 (en) INTEGRATED OR IMPLANTABLE BIOMATERIALS FOR FILLING OR COVERING CAVITIES AND LUMENS OF A BODY
JP2005329261A (en) Device and method for in vivo culturing of diverse tissue cells
WO1998057680A3 (en) Medical device for delivering a therapeutic substance
CA2246332A1 (en) Catheter based surgery
ATE219678T1 (en) ACTIVE SUBSTANCE FOR STIMULATION OF HARD TISSUE
EP0144534A3 (en) Prosthetic devices
EP0263490A3 (en) Sustained-release particulate preparation and process for preparing the same
CA2057277A1 (en) Biodegradable biocompatible anti-displacement device for prosthetic bone joints
JPH06502085A (en) Implants and their manufacturing methods
CN205391219U (en) Load rhBMP -2 slow release system's neck interbody fusion cage
WO2003008005A3 (en) Catheter and implants for the delivery of therapeutic agents to tissues
BG102375A (en) Inoculation biocompatible hydrophilic gel, method for its preparation and application
CN209285830U (en) Anchoring device
Horak et al. Hydrogels in endovascular embolization: IV. Effect of radiopaque spherical particles on the living tissue
EP0470474B1 (en) Implantable devices and materials
Gatzka et al. A novel ex vivo model for investigation of fluid displacements in bone after endoprosthesis implantation
CN219896036U (en) Liquid bone intervertebral space injection molding device

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed